摘要
肾小球疾病是我国终末期肾病最主要原因。其发病机制不明,主要涉及体液免疫和细胞免疫过程。近年,他克莫司治疗免疫性肾小球疾病在临床上取得较好疗效。本文综述了他克莫司治疗肾小球疾病的机制和治疗进展。
Glomerular diseases are leading causes of end stage renal disease. The pathogenesis is prevalently immune mediated: humoral and cell-mediated immunity are involved, although the rationale for an etiological treatment is still unknown. In recent years, therapy of tacrolimus has a good curative effect in clinic. This article is aimed to review recent novel insights into mechanism and treatment of tacrolimus to guide practice in clinic.
出处
《中华临床医师杂志(电子版)》
CAS
2014年第7期118-122,共5页
Chinese Journal of Clinicians(Electronic Edition)
关键词
肾疾病
免疫抑制剂
他罗利姆
Kidney diseases
Immunosuppressive agents
Tacrolimus